Alimera Sciences to Present at the Annual B. Riley Healthcare Conference

ATLANTA, Aug. 28, 2018 /PRNewswire/ -- Alimera Sciences (NASDAQ: ALIM), a global pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that Dan Myers, Chief Executive Officer, will be presenting at the annual B. Riley Healthcare Conference taking place September 4^th, 2018 at the Marriott East Side in New York, New York.

The Company's presentation will take place on Tuesday, September 4^th at 10:55AM Eastern Time, a webcast and audio replay will be available for 90 days online at www.alimerasciences.com.

About Alimera Sciences, Inc.
www.alimerasciences.com
Alimera, founded in June 2003, is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina because these diseases are not well treated with current therapies and will affect millions of people in our aging populations. Alimera's commitment to retina specialists and their patients is manifest in Alimera's product portfolio. For more information, please visit www.alimerasciences.com.

    For press inquiries:  For investor inquiries:

    Katie Brazel          CG Capital

    for Alimera Sciences  for Alimera Sciences

    404-317-8361          877-889-1972

    kbrazel@bellsouth.net investorrelations@cg.capital

View original content with multimedia:http://www.prnewswire.com/news-releases/alimera-sciences-to-present-at-the-annual-b-riley-healthcare-conference-300702974.html

SOURCE Alimera Sciences, Inc.